Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced...

Diabetes Research and Clinical Practice 2011 Vol. 93; Iss. 2

Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo

Yan Li, Sheng Zhao, Wei Zhang, Peng Zhao, Bing He, Na Wu, Ping Han
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
93
Year:
2011
Language:
english
Pages:
215
DOI:
10.1016/j.diabres.2011.03.036
File:
PDF, 1.06 MB
english, 2011
Conversion to is in progress
Conversion to is failed